Following the negative Phase I trial outcome for its autoimmune disease treatment, the company is cutting 73% of jobs.

Research led by Brock University has found a possible cure for lung diseases typically found in older adults, such as pulmonary fibrosis. The findings are published in the journal Aging Cell.

A recent study reveals the pivotal role of tristetraprolin (TTP), an RNA-binding protein, in regulating inflammatory responses in basophils, immune cells central to allergic reactions. The research ...

IGM Biosciences is again cutting staff as it scraps an autoimmune-drug trial after failing to achieve the desired results.

Learn to identify liver pain symptoms, understand common causes, and discover effective treatments. Insights on when to seek ...

Challenge trials help researchers study immune responses. Skeptics still doubt the approach is worth the risks ...

PAULS VALLEY, Okla. (KOKH) — People in Pauls Valley are starting the New Year with no hospital in their community. The Pauls ...

With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.

Glutathione tablets have interestingly assumed the role of the new revolutionary addition to the skincare system due to their ...

Additional clinical results from Phase 1/2 study of MRT-2359 in MYC-driven solid tumors, including biomarker and activity data, anticipated in Q1 2025 MRT-8102, a NEK7-directed MGD targeting diseases ...

(OTCQB: BIXT) (the "Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, fibrosis, stroke, dementia, and Alzheimer's disease, announced its ...

Learn about rheumatoid vasculitis, neutrophilic dermatoses, and other rheumatoid arthritis rashes, their symptoms, and when ...